SNOMED CT

Last uploaded: January 16, 2025
Preferred Name

Autoimmune hemolytic anemia mixed type
Synonyms

Autoimmune hemolytic anemia mixed type (disorder)

Autoimmune haemolytic anaemia mixed type

Definitions

Mixed autoimmune hemolytic anemia (mixed AIHA) is a type of autoimmune hemolytic anemia defined by the presence of both warm and cold autoantibodies, which have a deleterious effect on red blood cells at either body temperature or at lower temperatures. Diagnosis is based on clinical or laboratory evidence of hemolytic anemia and the detection of autoantibodies, usually both IgG and IgM, with the direct anti-globulin test (DAT) showing a pattern of IgG with complement C3, and the presence of cold agglutinins (IgM) in the serum at a significant titer. The disease responds to corticosteroids, and may be followed by remission, but usually runs a chronic course with intermittent exacerbations. Mixed autoimmune haemolytic anaemia (mixed AIHA) is a type of autoimmune haemolytic anaemia defined by the presence of both warm and cold autoantibodies, which have a deleterious effect on red blood cells at either body temperature or at lower temperatures. Diagnosis is based on clinical or laboratory evidence of haemolytic anaemia and the detection of autoantibodies, usually both IgG and IgM, with the direct anti-globulin test (DAT) showing a pattern of IgG with complement C3, and the presence of cold agglutinins (IgM) in the serum at a significant titre. The disease responds to corticosteroids, and may be followed by remission, but usually runs a chronic course with intermittent exacerbations.

ID

http://purl.bioontology.org/ontology/SNOMEDCT/718716008

Active

1

altLabel

Autoimmune hemolytic anemia mixed type (disorder)

Autoimmune haemolytic anaemia mixed type

CASE SIGNIFICANCE ID

900000000000448009

CTV3ID

XUts4

cui

C4305257

definition

Mixed autoimmune hemolytic anemia (mixed AIHA) is a type of autoimmune hemolytic anemia defined by the presence of both warm and cold autoantibodies, which have a deleterious effect on red blood cells at either body temperature or at lower temperatures. Diagnosis is based on clinical or laboratory evidence of hemolytic anemia and the detection of autoantibodies, usually both IgG and IgM, with the direct anti-globulin test (DAT) showing a pattern of IgG with complement C3, and the presence of cold agglutinins (IgM) in the serum at a significant titer. The disease responds to corticosteroids, and may be followed by remission, but usually runs a chronic course with intermittent exacerbations.

Mixed autoimmune haemolytic anaemia (mixed AIHA) is a type of autoimmune haemolytic anaemia defined by the presence of both warm and cold autoantibodies, which have a deleterious effect on red blood cells at either body temperature or at lower temperatures. Diagnosis is based on clinical or laboratory evidence of haemolytic anaemia and the detection of autoantibodies, usually both IgG and IgM, with the direct anti-globulin test (DAT) showing a pattern of IgG with complement C3, and the presence of cold agglutinins (IgM) in the serum at a significant titre. The disease responds to corticosteroids, and may be followed by remission, but usually runs a chronic course with intermittent exacerbations.

DEFINITION STATUS ID

900000000000074008

Effective time

20170131

Has causative agent

http://purl.bioontology.org/ontology/SNOMEDCT/3602003

Has clinical course

http://purl.bioontology.org/ontology/SNOMEDCT/90734009

Has interpretation

http://purl.bioontology.org/ontology/SNOMEDCT/281300000

http://purl.bioontology.org/ontology/SNOMEDCT/52101004

Has pathological process

http://purl.bioontology.org/ontology/SNOMEDCT/263680009

interprets

http://purl.bioontology.org/ontology/SNOMEDCT/14089001

http://purl.bioontology.org/ontology/SNOMEDCT/404227002

notation

718716008

Occurs in

http://purl.bioontology.org/ontology/SNOMEDCT/767023003

prefLabel

Autoimmune hemolytic anemia mixed type

Subset member

447562003~MAPRULE~TRUE

447562003~MAPTARGET~D59.1

6011000124106~MAPGROUP~1

447562003~MAPGROUP~1

447562003~CORRELATIONID~447561005

6011000124106~MAPCATEGORYID~447637006

6011000124106~MAPADVICE~ALWAYS D59.1

900000000000509007~ACCEPTABILITYID~900000000000548007

900000000000508004~ACCEPTABILITYID~900000000000548007

6011000124106~MAPADVICE~ALWAYS D59.13

6011000124106~MAPTARGET~D59.1

447562003~MAPPRIORITY~1

447562003~MAPCATEGORYID~447637006

6011000124106~MAPRULE~OTHERWISE TRUE

6011000124106~MAPCATEGORYID~447639009

6011000124106~MAPPRIORITY~1

6011000124106~MAPTARGET~D59.13

6011000124106~CORRELATIONID~447561005

6011000124106~MAPRULE~IFA 445518008 &#x7C; Age at onset of clinical finding (observable entity) &#x7C; < 29.0 days

900000000000497000~MAPTARGET~XUts4

447562003~MAPADVICE~ALWAYS D59.1

6011000124106~MAPPRIORITY~2

6011000124106~MAPTARGET~P55.8

6011000124106~MAPADVICE~IF AGE AT ONSET OF CLINICAL FINDING BEFORE 29.0 DAYS CHOOSE P55.8 &#x7C; MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT

tui

T047

Type ID

900000000000003001

900000000000013009

subClassOf

http://purl.bioontology.org/ontology/SNOMEDCT/398937006

http://purl.bioontology.org/ontology/SNOMEDCT/3978000

http://purl.bioontology.org/ontology/SNOMEDCT/707480001

http://purl.bioontology.org/ontology/SNOMEDCT/413834006

Delete Subject Author Type Created
No notes to display